New study shows that it is possible to prevent common

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Mar 17, 2014 at 4:15 AM

New study shows that it is possible to prevent common infections in children

Healthy children attending day-care centres have a significantly lower risk of getting diarrhoea or respiratory tract infections when given a daily supplement of Lactobacillus reuteri Protectis, a study in 336 children shows. ”Our study confirms earlier published data in proving that preventive use of L. reuteri Protectis in healthy children reduces diarrhoeic episodes. Moreover, the study demonstrated a reduction of respiratory tract infections in supplemented children”, says Pedro Gutiérrez-Castrellón, Head of Translational Research Unit on Pediatric Nutrition, Hospital General Dr. Manuel Gea González, Mexico and Academic Professor of Public Health at Medicine Faculty ULSA, Mexico. Fewer sick days with Protectis During the three months’ long intervention the children receiving Lactobacillus reuteri Protectis had 67 per cent fewer days with diarrhoea or respiratory tract infection than children in the placebo group. When infected the episodes were also shorter than in the placebo group; diarrhoea was shortened by one day and the duration of respiratory tract infection was three days shorter compared to placebo. Moreover, the children supplemented by Lactobacillus reuteri Protectis had fewer days with fever, used less antibiotics and were less absent from day-care. Healthier children save costs Paediatric gastrointestinal and respiratory tract infections also lead to considerable costs for the community, for visiting the doctor, medication and for being absent from school and work. By calculating the direct costs the investigators demonstrated that daily use of Lactobacillus reuteri Protectis saves costs both for the family and the community. “The intervention was shown to be cost effective and therefore, both in terms of reducing disease and from an economic perspective, this trial adds independent support to previous evidence that daily preventive use of L. reuteri Protectis could be valuable for families and the society”, adds Dr Gutierrez-Castrellon. The study was published in the highly regarded medical journal Pediatrics on 17 March 2014 (http://pediatrics.aappublications.org/content/early/2014/03/11/peds.2013 -0652.abstract). Study details are found through the attached link (http://www.biogaia.com/sites/biogaia.com/files/Gutierrez_2014_Study_design . pdf). “This is yet another study that shows that L. reuteri Protectis has preventive effects in common infections. In several mature markets we can now actively broaden our sales efforts to the prevention market, which of course has a much bigger potential compared to the treatment market”, says Peter Rothschild, President, BioGaia. The new results confirm earlier data Several studies have already shown that Lactobacillus reuteri Protectis can reduce the risk of suffering from various conditions. A study from 2011 showed that Lactobacillus reuteri Protectis could prevent diarrhoea and affect height and weight in children in Indonesia (Agustina). In 2005 a study was published in which Lactobacillus reuteri Protectis was shown to reduce the risk of fever, respiratory tract infection and need of antibiotics. The children who received Protectis were healthier and had fewer sick days than the children who received placebo (Weizman). A Swedish study performed with employees at TetraPak showed that those who received a daily supplementation of Lactobacillus reuteri Protectis had fewer sick days (Tubelius, 2005). Latest press releases from BioGaia 2014-03-12 BioGaia enters new, extended agreement with Nestlé 2014-02-17 BioGaia receives the first instalment of additional payment from Nestlé 2014-02-12 BioGaia AB: Year-end report 2013 BioGaia has published this information in accordance with the Swedish Securities Market Act. The information was issued for publication on 17 March 2014, 09:00 am CET. For additional information please contact Peter Rothschild, Chief Executive Officer, BioGaia: 46 8 555 293 00 BioGaia is a healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri, which has probiotic, health -enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap list of the NASDAQ OMX Nordic Exchange Stockholm. www.biogaia.com

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

FileInvite Transforms Complex Lending with Bold Platform Relaunch

A New Era for Lending Documentation If you've been drumming your fingers waiting on loan paperwork to get sorted, FileInvite's latest move might just be the caffeine kick the lending world needs. Announced at the NAGGL Annual Conference, their souped-up platform has been redesigned as the beating heart of lending documentation. This isn't just a facelift folks—it's an...

Vanessa Hering's Empathetic Model Wins 2026 Herizon Award

Recognizing a Game-Changer in Financial Wellness Vanessa Hering's name isn't just getting thrown around for no reason, folks. She's the client success officer at Beyond Finance, a heavyweight in the financial wellness arena, and she's just snagged the 2026 Herizon Award. This ain't some run-of-the-mill accolade; it acknowledges the profound changes she's spearheaded in...

LONGi Achieves 10th BNEF Tier 1 Listing Amidst Stricter Rules

LONGi Surpasses New BNEF Barriers with Ease Alright, let's dig into the meat of the matter today. LONGi has snagged its 10th straight spot in BloombergNEF's (BNEF) Tier 1 list of global energy storage manufacturers. And mind you, that's no small potatoes, especially with stricter financing demands rearing their hefty heads this quarter. Non-Recourse Financing: A Tougher...

RepData's New Platform Redefines Market Research Game

Ever look at your market research and think, 'Is this really the best we can do?' RepData just rolled up like they own the place with their Verified Intelligence Platform (VIP), promising to make those wild data quality doubts a thing of the past. RepData’s Game-Changer in Research RepData's stepping into the ring with their VIP, aiming to shake up the way research...

Minghui and ASKA Seal Major Licensing Deal for MHB018A

Breaking New Ground in Thyroid Eye Disease Treatment If there's one thing that keeps the biopharma world on its toes, it's the relentless pursuit of groundbreaking treatments. And folks, let me tell you, the latest tie-up between Minghui Pharmaceutical and ASKA Pharmaceutical has struck a chord. This union with MHB018A at its core might be one of those watershed moments...

Atlas-SSI Expands Grip in Water Control Space

Atlas-SSI Makes Waves with Linita Acquisition Here's the kind of news that makes an old market hound sit up and take notice. Atlas-SSI, the big cheese in North America for water management solutions, has gone and snagged Linita Design & Manufacturing. Why's this worth talking about? Linita isn't just any player—they've been crafting custom-engineered hydro-mechanical...

OSL Unveils Instant Redemption for USDGO Plus SP

OSL's New Move: Instant Redemption on the Table Alright, let's chew over OSL's latest gambit—you know, those folks (HKEX: 863) who are knee-deep in the digital currency swamp. They've launched this "Instant Redemption" feature for these fancy real-world asset products, and USDGO Plus SP is right there at the forefront. Getting the Fine Print Straight Now, not just...

SportsMed Expands to 58 Clinics, New Opening in Jersey City

SportsMed Physical Therapy Expands with New Clinic Well, here we are, talking about expansion. And not just any expansion—I'm talking about SportsMed Physical Therapy flexing its muscles in Jersey City Heights, boosting their count to 58 clinics scattered across New Jersey and Connecticut. It's like watching a network of care roots spreading deeper into the region, and...

Business Formations in 2026: A Blow-by-Blow Analysis

Surging Entrepreneurial Spirit in 2026 Just when you’d think economic jitters would slow us down, American entrepreneurship is out there smashing records like a bulldozer through a picket fence. September 2026 saw a staggering 562,579 new business formations—the highest September tally ever logged. That's no fluke. This momentum hasn’t let up all year, and it paints...

Cathy Craig Drives $163M in Broken Bow Airbnb Deals

Investors Find Gold in Broken Bow’s Airbnb Market When did Broken Bow, Oklahoma, become the go-to spot for adventurous investors looking to park their cash in timberland sanctuary cabins? Well, Cathy Craig seems to know the secret sauce, having navigated over $163 million worth of Airbnb and VRBO cabin deals for her clients since 2021. Her knack for spotting cabins that...